StockpollyBeta
Get App
Delisting riskPopularity #4,965
SNOA · NASDAQ · Drug Manufacturers - Specialty & Generic

Sonoma Pharmaceuticals (SNOA)

Develops and manufactures shelf-stable hypochlorous-acid products for wound, skin, eye, foot, animal, and surface care.

$1.27
vs last close+0.02 (+1.60%)

In millions of USD, except per-share figures

In millionsQ2 FY24Sep 2023Q3 FY24Dec 2023Q4 FY24Mar 2024Q1 FY25Jun 2024Q2 FY25Sep 2024Q3 FY25Dec 2024Q4 FY25Mar 2025Q1 FY26Jun 2025Q2 FY26Sep 2025Q3 FY26Dec 2025Q4 FY26Mar 2026Q1 FY27Jun 2026
Revenue333344446466
Cost of revenue222222233334
Gross profit111111212223
223222232233
Research & development110010011111
Selling, general & administrative222222222222
Operating income−1−1−1−1−1−1−1−10−100
000000000000
Other non-operating income000000000000
Income before tax−1−1−1−10−1−1−1−1−100
Income tax expense000000000000
Net income from continuing operations−1−1−1−1−1−1−1−1−1−1−10
Net income−1−1−1−1−1−1−1−1−1−1−10
EPS, basic−$2.87−$1.59−$1.37−$1.34−$0.59−$0.63−$0.63−$0.76−$0.32−$0.48−$0.33−$0.09
EPS, diluted−$2.87−$1.59−$1.37−$1.34−$0.59−$0.63−$0.63−$0.76−$0.32−$0.48−$0.33−$0.09
Weighted average shares, basic111111122224
Weighted average shares, diluted111111122224
EBITDA−1−1−1−1−1−1−1−10−100
Depreciation & amortization000000000000
EBIT−1−1−1−1−1−1−1−10−100